The effect of the anabolic steroid stanozolol on tissue plasminogen activator activity and plasmin inhibition in the rat
- 1 September 1980
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 36 (9) , 1079-1080
- https://doi.org/10.1007/bf01965980
Abstract
The anabolic steroid stanozolol administered orally in male Sprague-Dawley rats induced a dose- and time-dependent increase in tissue plasminogen activator activity. The increase was highest in lung, lowest in heart, and intermediate in aorta and kidney. A slight increase in plasmin inhibition was noted only in the heart.This publication has 11 references indexed in Scilit:
- Normal liver actually possesses a high vascular plasminogen activator activityCellular and Molecular Life Sciences, 1979
- Sex related fibrinolytic activity in rat tissuesCellular and Molecular Life Sciences, 1978
- Regions of Constantly Increased Plasminogen Activator Activity along the Intima of the Normal AortaPathophysiology of Haemostasis and Thrombosis, 1978
- Effect of ethyloestrenol on fibrinolysis in the vessel wall.BMJ, 1976
- Fibrinolytic Enhancement by Stanozolol: A Double Blind TrialBritish Journal of Haematology, 1972
- Metformin and stanozolol in blood fibrinolytic activity.BMJ, 1971
- Effect of Treatment with Combined Phenformin and Ethyloestrenol on the Coagulation and Fibrinolytic SystemsScandinavian Journal of Haematology, 1970
- EFFECTS ON PLATELET STICKINESS AND FIBRINOLYSIS OF PHENFORMIN COMBINED WITH ETHYLŒSTRENOL OR STANOZOLOLThe Lancet, 1970
- Phenformin and stanozolol in blood fibrinolytic activity.BMJ, 1970